Atlas Trials

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

Clinical trial NCT02392117 · COMPLETED

Trial details

NCT number
NCT02392117
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2015-03-16
Primary completion
2018-03-19
Enrollment
1262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.